VSee Health CFO receives multiple stock awards

Leonard Jerry reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Leonard Jerry reported acquisition or exercise transactions in this Form 4 filing.

VSEE HEALTH, INC. Chief Financial Officer Leonard Jerry received multiple grants of common stock as equity compensation. On March 23, 2026, he was awarded grants including 66,845 shares at $0.37, 40,984 shares at $0.61, 21,552 shares at $1.16, and 20,833 shares at $1.20 per share.

Footnotes explain these shares were issued under the 2024 Incentive Plan as quarterly equity awards owed for the quarters ended March 31, June 30, September 30, and December 31, 2025, with each grant amount based on the common stock closing price on the respective quarter-end date.

Insider Trade Summary

Grant/Award: 150,214 shares

Grant/Award 4 txns

Insider Leonard Jerry

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.0001 per share	66,845	$0.37	$25K
Grant/Award	Common Stock, par value $0.0001 per share	40,984	$0.61	$25K
Grant/Award	Common Stock, par value $0.0001 per share	21,552	$1.16	$25K
Grant/Award	Common Stock, par value $0.0001 per share	20,833	$1.20	$25K

Holdings After Transaction: Common Stock, par value $0.0001 per share — 581,557 shares (Direct)

Footnotes (4)

1. F1. Reflects shares of common stock issued to the reporting person under the issuer's 2024 Incentive Plan (the "Incentive Plan") as the quarterly equity award owed by the issuer to the reporting person for the quarter ended December 31, 2025 pursuant to the Executive Employment Agreement between the reporting person and the issuer dated December 10, 2025 (the "Employment Agreement"). The number of shares issued to the reporting person is based on the closing price of the common stock on December 31, 2025.
2. F2. Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended September 30, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on September 30, 2025.
3. F3. Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended June 30, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on June 30, 2025.
4. F4. Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended March 31, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on March 31, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VSEE CFO Leonard Jerry report on this Form 4 for VSEE?

Leonard Jerry reported receiving multiple grants of VSEE common stock as equity compensation. These were stock awards under the 2024 Incentive Plan, not open-market purchases, and relate to quarterly equity awards owed for various 2025 quarters under his Executive Employment Agreement.

How many VSEE shares were granted to the CFO on March 23, 2026?

On March 23, 2026, the CFO received several stock grants, including blocks of 66,845 shares at $0.37, 40,984 shares at $0.61, 21,552 shares at $1.16, and 20,833 shares at $1.20 per share, all as compensation awards rather than market purchases.

What plan governs the VSEE stock awards granted to the CFO on this Form 4?

The stock awards were issued under VSEE’s 2024 Incentive Plan. The Form 4 states these grants represent quarterly equity awards owed to the CFO under his Executive Employment Agreement, using the company’s incentive equity framework instead of cash for part of his compensation.

Which periods do the VSEE CFO’s reported equity awards on this Form 4 relate to?

The reported equity awards relate to quarters ended March 31, June 30, September 30, and December 31, 2025. Each grant corresponds to a specific quarter’s equity award owed under the Executive Employment Agreement and is tied to that quarter’s closing share price.

How were the numbers of VSEE shares in each CFO award calculated?

The number of shares in each award was based on VSEE’s common stock closing price on the relevant quarter-end date. The filing notes separate calculations using closing prices on March 31, June 30, September 30, and December 31, 2025 for the respective quarterly equity awards.

Does the VSEE CFO Form 4 indicate any open-market buying or selling of shares?

The Form 4 reflects only grant-type transactions coded as acquisitions (code A) under the incentive plan. It does not show any open-market purchases or sales; instead, it documents equity compensation awards tied to the CFO’s employment agreement for 2025 quarters.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 04:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leonard Jerry

(Last) (First) (Middle)

C/O VSEE HEALTH, INC.

980 N FEDERAL HWY #304

(Street)

BOCA RATON FLORIDA 33432

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VSEE HEALTH, INC. [ VSEE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	03/23/2026		A		66,845	A	$0.37(1)	710,938	D
Common Stock, par value $0.0001 per share	03/23/2026		A		40,984	A	$0.61(2)	644,093	D
Common Stock, par value $0.0001 per share	03/23/2026		A		21,552	A	$1.16(3)	603,109	D
Common Stock, par value $0.0001 per share	03/23/2026		A		20,833	A	$1.2(4)	581,557	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of common stock issued to the reporting person under the issuer's 2024 Incentive Plan (the "Incentive Plan") as the quarterly equity award owed by the issuer to the reporting person for the quarter ended December 31, 2025 pursuant to the Executive Employment Agreement between the reporting person and the issuer dated December 10, 2025 (the "Employment Agreement"). The number of shares issued to the reporting person is based on the closing price of the common stock on December 31, 2025.

2. Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended September 30, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on September 30, 2025.

3. Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended June 30, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on June 30, 2025.

4. Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended March 31, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on March 31, 2025.

	/s/ Jerry Leonard	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)